A study published in the journal “Progress in Cardiovascular Diseases” refutes the frequently repeated claims that a comprehensive salt reduction would not produce any overall health benefits, or would even increase diseases and shorten the life-span.
The Office of Research on Women?s Health (ORWH) and the Trans-NIH Working Group for Research in Chronic Fatigue Syndrome (CFSWG) of the National Institutes of Health (NIH) are pleased to announce seven (7) awards in Chronic Fatigue Syndrome (CFS) research. The proposed studies will help researchers understand how the diverse symptoms in CFS are related to the interactions between the immune and neurological systems ? an important step towards developing effective treatments for a disabling condition.
In the largest, most comprehensive study of its kind to date, researchers supported by the National Institutes of Health (NIH) showed clinical improvements out to one year when stroke survivors who had lost function in one arm were given a unique, two-week rehabilitation regimen.
“Cardiovascular disease remains our country’s biggest killer,” said Minister Clement. “Canada’s new government is following through on our promise to develop a heart health strategy. The strategy developed will ensure crucial information on prevention and treatment is available quickly and effectively to all provinces and territories. A new Heart Health Strategy will save lives.”
Smokers will soon be confronted with a new set of graphic warnings on their cigarette packets, with seven gruesome pictures to be added to those already on display. From today, tobacco manufacturers can introduce a second set of seven images on cigarette packs, and all cigarette packs must be printed with this second set by 1 March 2007.
Breast cancer survivors might one day avoid the prospect of invasive breast reconstruction surgery, opting instead for an approach that would involve using stem cells derived from their own fat, suggest University of Pittsburgh researchers who are studying the potential these cells may have for regenerating new breast tissue.
The experience of racial discrimination may be a key factor in explaining why African Americans have higher rates of obesity and suffer at higher rates from such diseases as diabetes and cardiovascular disorders, according to UCLA researchers. Repeated responses to such discrimination — which include elevated blood pressure and heart rate — can cause enormous stress on a person’s mental and physical health, according to research scheduled to be published in Volume 58 of the Annual Review of Psychology.
With the research support from the University of Wisconsin-Milwaukee, a Wisconsin biotech company has found that a compound from a protein found in jellyfish is neuro-protective and may be effective in treating neurodegenerative diseases.
A new obesity pill that helps to control blood sugar levels could treat patients with type 2 diabetes, researchers say. They found that the Sanofi-Aventis drug Acomplia, which is also known as rimonabant, also reduced risk factors for heart disease in patients with type 2 diabetes who had not responded to standard treatments.
Results from the SAINT II (Stroke Acute Ischemic NXY-059 Treatment) trial, announced today by AstraZeneca, showed that the investigational drug NXY-059 did not meet its primary outcome of a statistically significant reduction in stroke-related disability, as assessed by the modified Rankin Scale (mRS) (p=0.33, odds ratio 0.94) compared to placebo.